Back in early December, Corazon Gold Corporation de-listed from the TSXV and reemerged as Nanosphere Health Sciences Inc (Ticker NSHS) on the CSE.
They raised $5.9M in a Private Placement and acquired Nanosphere (US based company) for its patent-pending Nanosphere Delivery System which it aims to deploy to revolutionize the way cannabis is administered, along with other substances.
Their disruptive approach has already been launched throughout Colorado and is stocked in 70 stores under the brand:
Their product description is quite technical and wordy but here is it anyways:
“Evolve’s NanoSerum™ is a fast-acting, ultra-strength transdermal formula infused with nano-encapsulated cannabis and cannabis extracts. NanoSerum™ immediately penetrates the skin to deliver direct-focused relief from pain, inflammation and anxiety and intelligently carries a full spectrum of cannabinoids and phytochemicals to receptors throughout the body for systemic healing”
Essentially it is a gel that is absorbed within seconds of applying. Check out their video which shows how it works in more detail.
This product is the first clinically tested trans-dermal cannabis product to relieve pain in minutes. This product can be marketed in other states that are legalized or are in the process of becoming legalized (California, Nevada etc.). It can also be used on the medical side for those states which have no plans for recreational sales.
This product has the potential to disrupt the industry and offer a unique and safe way to administer the drug versus smoking, vaping and edibles.
Their technology is award winning and more effective in dosage and speed of transmission versus its peers at a much lower market cap.
There are also multiple applications beyond just the Cannabis market.
This one has remained under the radar for most Cannabis Investors but eventually the street will start to take notice and this one should be set for rapid growth.
Fortune Favours the Bold
Follow us on Twitter & Facebook to stay ahead of the game